Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 5, 2010, Pages 1305-1312

  Szymańska, Ewa ^a   Markuszewski, Michał J ^a,b   Markuszewski, Marcin ^a   Kaliszan, Roman ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Bioinformatics; Biomarkers; Capillary electrophoresis; Metabolomics; Nucleosides; Urogenital tract cancer

Indexed keywords

1 METHYLADENOSINE; 5 METHYLURIDINE; 6 N METHYLADENOSINE; ADENOSINE; CYTIDINE; DIHYDROURIDINE; GUANOSINE; INOSINE; N2,N2 DIMETHYLGUANOSINE; N4 ACETYLCYTIDINE; NUCLEOSIDE; PSEUDOURIDINE; UNCLASSIFIED DRUG; URIDINE; XANTHOSINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER PATIENT; CAPILLARY ELECTROPHORESIS; CLUSTER ANALYSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; K NEAREST NEIGHBOR; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RELIABILITY; SENSITIVITY AND SPECIFICITY; TESTIS CANCER; URINALYSIS; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CHEMISTRY, PHARMACEUTICAL; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; MALE; METABOLOME; MIDDLE AGED; NUCLEOSIDES; UROGENITAL NEOPLASMS; YOUNG ADULT;

EID: 77955918060     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.031     Document Type: Article

References (33)

1. Schnackenberg L.K. Global metabolic profiling and its role in system biology to advanced personalized medicine in the 21st century. Expert Rev. Mol. Diagn. 2007, 7:247-259.
2. Nordstrom A., Lewensohn R. Metabolomics: moving to the clinic. J. Neuroimmun. Pharmacol. 2010, 5:4-17.
3. Spratlin J.L., Serkova N.J., Eckhardt S.G. Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res. 2009, 15:431-440.
4. Ma Y., Liu G., Du M., Stayton I. Recent developments in the determination of urinary cancer biomarkers by capillary electrophoresis. Electrophoresis 2004, 25:1473-1484.
5. Melichar B., Solichova D., Svobodova I., Melicharova K. Neopterin in renal cell carcinoma: inhalational administration of interleukin-2 is not accompanied by a rise of urinary neopterin. Luminescence 2005, 20:310-314.
6. Seidel A., Brunner S., Seidel P., Fritzm G.I., Herbarth O. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br. J. Cancer 2006, 94:1726-1733.
7. Byun J.A., Lee S.H., Jung B.H., Choi M.H., Moon M.H., Chung B.C. Analysis of polyamines as carbamomyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2008, 22:73-80.
8. Kim K.R., La S., Kim A., Kim J.H., Liebich H.M. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from uterine myoma and cervical cancer patients. J. Chromatogr. B 2001, 754:97-106.
9. Masaki Y., Itoh K., Sawaki T., Karasawa H., Kawanami T., Fukushima T., Kawabata H., Wano Y., Hirose Y., Suzuki T., Sugai S., Umehara H. Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters. Clin. Chim. Acta 2006, 371:148-151.
10. Yang J., Xu G., Zheng Y., Kong H., Pang T., Lv S., Yang O. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B 2004, 813:59-65.
11. Zheng Y.F., Kong H.W., Xiong J.H., Lv S., Xu G.W. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Clin. Biochem. 2005, 38:4-30.
12. Xu G., Liebich H.M. Normal and modified nucleosides in urine as potential tumor markers determined by MEKC and HPLC. Am. Clin. Lab. 2001, 3:22-32.
13. Gehrke C.W., Kuo K.C., Davis G.E., Suits R.D., Waalkes T.P., Borek E. Quantitative high-performance liquid chromatography of nucleosides in biological materials. J. Chromatogr. 1978, 150:455-476.
14. Zheng Y., Xu G., Yang J., Zhao X., Pang T., Kong H. Determination of urinary nucleosides by direct injection and coupled-column high-performance liquid chromatography. J. Chromatogr. B 2005, 819:85-90.
15. Cho S.-H., Jung B.H., Lee S.H., Lee W.-Y., Kong G., Chung B.C. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2006, 20:1229-1236.
16. Kim K.-R., La S., Kim A., Kim J.-H., Liebich H.M. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from uterine myoma and cervical cancer patients. J. Chromatogr. B 2001, 754:97-106.
17. Zhang Y.-X. Artificial neural networks based on principal component analysis input selection for clinical pattern recognition analysis. Talanta 2007, 73:68-75.
18. Helboe T., Hansen S.H. Separation of nucleosides using capillary electrochromatography. J. Chromatogr. A 1999, 836:315-324.
19. Markuszewski M.J., Struck W., Waszczuk-Jankowska M., Kaliszan R. Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques. Electrophoresis 2010, 31:2300-2310.
20. Szymańska E., Markuszewski M.J., Bodzioch K., Kaliszan R. Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction. J. Pharm. Biomed. Anal. 2007, 44:1118-1126.
21. Zhang M.H., Xu Q.S., Massart D.L. Boosting partial least squares. Anal. Chem. 2005, 77:1423-1431.
22. Kennard R.W., Stone L.A. Computer-aided design of experiments. Technometrics 1969, 11:137-148.
23. Stanimirova I., Kubik A., Walczak B., Einax J.W. Discrimination of biofilm samples using pattern recognition techniques. Anal. Bioanal. Chem. 2008, 390:1273-1282.
24. Snee R.D. Validation of regression models. Methods and examples. Technometrics 1977, 19:415-428.
25. Szymańska E., Markuszewski M.J., Capron X., van Nederkassel A.-M., Vander Heyden Y., Markuszewski M., Krajka K., Kaliszan R. Increasing conclusiveness of metabonomic studies by cheminformatic preprocessing of capillary electrophoretic data on urinary nucleoside profiles. J. Pharm. Biomed. Anal. 2007, 43:413-420.
26. Liebich H.M., Xu G., Di Stefano C., Lehmann R. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. J. Chromatogr. A 1998, 793:341-347.
27. Slupsky C.M., Rankin K.N., Wagner J., Fu H., Chang D., Weljie A.M., Saude E.J., Lix B., Adamko D.J., Marrie T.J. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolic profiles. Anal. Chem. 2007, 79:6995-7003.
28. Wishart D.S., et al. HMDB: the human metabolome database. Nucleic Acids Res. 2007, 35:D521-D526.
29. Schram K.H. Urinary nucleosides. Mass Spectrom. Rev. 1998, 17:131-251.
30. Kind T., Tolstikov V., Fiehn O., Weiss R.H. A comprehensive urinary metabolic approach for identifying kidney cancer. Anal. Biochem. 2007, 363:185-195.
31. Daszykowski M., Wu W., Nicholls A.W., Ball R.J., Czekaj T., Walczak B. Identifying potential biomarkers in LC-MS data. J. Chemometr. 2007, 21:292-302.
32. Sozen S., Eskicorabci S., Ozen H. Urinary markers for urothelial cancer. Br. J. Urol. 2003, 92:531-533.
33. Schiffer E. Biomarkers for prostate cancer. World J. Urol. 2007, 25:557-562.